Expression of delta-aminolevulinate synthase durin erythroid differentiation

红系分化过程中δ-氨基乙酰丙酸合酶的表达

基本信息

  • 批准号:
    05670136
  • 负责人:
  • 金额:
    $ 1.34万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1993
  • 资助国家:
    日本
  • 起止时间:
    1993 至 1994
  • 项目状态:
    已结题

项目摘要

Mouse erythroleukemia (MEL) cells undergo erythroid differentiation after treatment of dimethylsulfoxide (DMSO).Recently, we established DR cell, a clone of MEL cell, which could not undergo erythroid differentiation after DMSO treatment. Analysis revealed a deficiency of erythroid-specific delta-aminolevulinate synthase (ALAS-E) in DR cells. In addition, gene activation of delta-aminolevulinate dehydratase, porphobilonogen deaminase, and uroporphyrinogen decarboxylase-after DMSO treatment were reduced to approx. 1/3 of those in wild type cells.In the present study we evidenced that deficiency of heme in DR cells resulted in reduced concentrations of minas encoding ferrochelatase and beta-globin. Further studies suggest that insufficient supply of heme inhibits the gene activation of NF-E2. It is, therefore, suggested that NF-E2 might regulate heme biosynthesis in erythroid cells in a positive feedbach manner.Then, we have developed MEL cell lines, whose ALAS-E levels were declined by antisense RNA of the enzyme. Antisense RNA expression caused reductions not only in ALAS-E expression but also in the other heme pathway enzymes. These observations are in good agreement with those observed in DR cells. Furthermore, expression of ALAS-E antisense RNA also reduced NF-E2 mRNA.Thus, it is highly probable that NF-E2 plays one of the significant roles on positive feedback regulation of heme in erythroid cells.
小鼠红白血病(MEL)细胞经二甲基亚砜(DMSO)处理后可向红系分化,我们建立了MEL细胞的克隆--DR细胞,该细胞经DMSO处理后不能向红系分化。分析显示DR细胞中红系特异性δ-氨基乙酰丙酸合酶(ALAS-E)缺乏。此外,在DMSO处理后,δ-氨基乙酰丙酸酯酶、胆色素原脱氨酶和尿卟啉原脱羧酶的基因活化降低至约100%。在本研究中,我们证明了在DR细胞中血红素的缺乏导致编码亚铁螯合酶和β-珠蛋白的minas浓度降低。进一步的研究表明,血红素供应不足会抑制NF-E2的基因激活。因此,我们认为NF-E2可能以正反馈的方式调节红系细胞血红素的合成。反义RNA表达不仅导致ALAS-E表达减少,还导致其他血红素途径酶减少。这些观察结果与在DR细胞中观察到的结果非常一致。ALAS-E反义RNA的表达也降低了NF-E2 mRNA的表达,因此,NF-E2很可能在红系细胞血红素的正反馈调节中起重要作用。

项目成果

期刊论文数量(50)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
H.Fujita et al.: "Regulation of Heme Protein Synthesis" AlphaMed Press, 139 (1994)
H.Fujita 等人:“血红素蛋白合成的调节”AlphaMed Press,139 (1994)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
N.Komatsu and H.Fujita: "Induced megakaryocytic maturation of the human leukemia cell line,UT-7,results in down-modulation of erythropoietin receptor gene" Cancer Res.53. 1156-1161 (1993)
N.Komatsu 和 H.Fujita:“诱导人类白血病细胞系 UT-7 巨核细胞成熟,导致促红细胞生成素受体基因下调”Cancer Res.53。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
N.Komatsu, M.Yamamoto, H.Fujita, A.Niwa, K.Hatake, T.Endo, H.Okano, T.Katsube, Y.Fukumaki, S.Sassa & Y.Miura: "Establishment and characterization of an erythropoietin-dependent subline, UT-7/Epo derived from human leukemia cell line, UT-7." Blood. 82. 456
N.小松、M.Yamamoto、H.Fujita、A.Niwa、K.Hatake、T.Endo、H.Okano、T.Katsube、Y.Fukumaki、S.Sassa
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FUJITA Hiroyoshi其他文献

FUJITA Hiroyoshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FUJITA Hiroyoshi', 18)}}的其他基金

Development of new protective method against environmental factors.
开发针对环境因素的新保护方法。
  • 批准号:
    23659324
  • 财政年份:
    2011
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Protection against Asbestosis.
预防石棉肺。
  • 批准号:
    22390119
  • 财政年份:
    2010
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Regulation of transcription by heme with sperm reference to cell differentiation
血红素对精子转录的调节与细胞分化有关
  • 批准号:
    14370048
  • 财政年份:
    2002
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Evaluation of toxicities of porphyrin derivatives and its possible application
卟啉衍生物的毒性评价及其可能的应用
  • 批准号:
    13557028
  • 财政年份:
    2001
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular Mechanisms Involved in Oxygen Sensing by Heme.
血红素参与氧传感的分子机制。
  • 批准号:
    10044230
  • 财政年份:
    1998
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Molecular Mechanisms for delta-Aminolevulinate Synthase Gene
δ-氨基乙酰丙酸合酶基因的分子机制
  • 批准号:
    08457044
  • 财政年份:
    1996
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular Mechanism of Erythroid Differentiation
红系分化的分子机制
  • 批准号:
    07044217
  • 财政年份:
    1995
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for international Scientific Research

相似海外基金

Exploring lineage determining factors for human megakaryocytes or erythroid differentiation in patients with JAK2 V617F by a novel fluctuation-based methodology
通过基于波动的新型方法探索 JAK2 V617F 患者中人类巨核细胞或红系分化的谱系决定因素
  • 批准号:
    22K08450
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms that regulate erythroid differentiation of hematopoietic stem cells
造血干细胞红系分化的调节机制
  • 批准号:
    10509652
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
Mechanisms that regulate erythroid differentiation of hematopoietic stem cells
造血干细胞红系分化的调节机制
  • 批准号:
    10647781
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
Metabolic Control of Erythroid Differentiation
红细胞分化的代谢控制
  • 批准号:
    10350557
  • 财政年份:
    2020
  • 资助金额:
    $ 1.34万
  • 项目类别:
Metabolic Control of Erythroid Differentiation
红细胞分化的代谢控制
  • 批准号:
    10091511
  • 财政年份:
    2020
  • 资助金额:
    $ 1.34万
  • 项目类别:
Metabolic Control of Erythroid Differentiation
红细胞分化的代谢控制
  • 批准号:
    9885429
  • 财政年份:
    2020
  • 资助金额:
    $ 1.34万
  • 项目类别:
Mechanism for the roles of cholesterol-binding membrane protein TSPO2 in terminal erythroid differentiation
胆固醇结合膜蛋白TSPO2在红系终末分化中的作用机制
  • 批准号:
    20H03138
  • 财政年份:
    2020
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Delineating the functions of EKLF during mammalian terminal erythroid differentiation
描述 EKLF 在哺乳动物终末红细胞分化过程中的功能
  • 批准号:
    10440030
  • 财政年份:
    2018
  • 资助金额:
    $ 1.34万
  • 项目类别:
Delineating the functions of EKLF during mammalian terminal erythroid differentiation
描述 EKLF 在哺乳动物终末红细胞分化过程中的功能
  • 批准号:
    10326466
  • 财政年份:
    2018
  • 资助金额:
    $ 1.34万
  • 项目类别:
Delineating the functions of EKLF during mammalian terminal erythroid differentiation
描述 EKLF 在哺乳动物终末红细胞分化过程中的功能
  • 批准号:
    10117229
  • 财政年份:
    2018
  • 资助金额:
    $ 1.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了